Monthly Archives: April 2012

Sherley v. Sibelius – The Undead Threat To Stem Cell Funding

Green Energy Sources When a three judge panel of the US Court of Appeals for the D.C. Cir. dismissed a preliminary injunction obtained by plaintiffs in April 2011, and the lower court judge then  dismissed plaintiffs’ suit to block the … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , , , , , | Leave a comment

Eurand v. Mylan –A “School Of Obviousness”

When I read the April 16th decision (App. No. 2011-1399, -1409 (Fed. Cir. April 16, 2012)) (a copy is available at the end of this post) in which a Fed. Cir. panel of Newman, O’Malley and Reyna reversed a district … Continue reading

Posted in Obviousness | Tagged , , , , , , , , , , , , | Leave a comment

Major Changes to IP Law in Australia Enacted

This guest post by Tom Gumley, PhD, a partner in the well-known Freehills Patent and Trademark firm provides a lengthy guide to the changes wrought by Australia’s new patent law, that was enacted on April 15, 2012. The law brings … Continue reading

Posted in Int'l Practice and Policy | Tagged , , , , , , , , | Leave a comment

Supreme Court Reverses In Caraco Appeal

Today, in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk, in an opinion authored by Justice Kagan (a copy can be found at the end of this post), the Court reversed the Fed. Cir.’s divided 2010 decision that an ANDA filer … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , , , | 1 Comment